Azin Parhizgar
Director @ CroíValve
San Francisco, United States
Azin Parhizgar is an experienced and successful medical device industry executive and entrepreneur. Prior to joining Claret Medical, she served as the Chief Operating Officer of Conor Medsystems which led to the acquisition of the company by Johnson & Johnson, Inc. in 2007. She spent one year post-merger with Johnson & Johnson for fullintegration of the companies. Between 1996-2000 she held the positon of Executive Vice President for Arterial Vascular Engineering, which was acquired by Medtronic. She spent two years at Medtronic post-merger in increasing roles of responsibility leading to her role as Executive Vice President of Emerging Ventures and New Technologies. Dr. Parhizgar has served as an advisor to emerging medical device technology companies including several Board of Directors and Scientific Advisory Board positions. Dr. Parhizgar received both her Ph.D. in Cell, Gene and Tissue Engineering and her M.Sc. in Biomechanical Engineering and Artificial Organ Design from Brown University, Providence, RI.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Azin Parhizgar invests in
Stages Azin Parhizgar invests in
Countries Azin Parhizgar invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 1 (100%)
- Medical Device 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Moray Medical
|
Moray Medical develops a structural heart robotic delivery systems for edge-to-edge valve leaflet repair.Moray Medical is working to improve the quality of life for the millions suffering from leaky heart valves. Using our proprietary microfluidic robotics, more cardiologists can safely and cost-effectively treat the large number of patients whoneed mitral valve clip therapies. | $5.7M / Seed / Apr 12, 2021 |
Co-Investors
About CroíValve
CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
CroíValve Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Azin Parhizgar
Director
|
|||
Lucy O'Keeffe
Co-Founder & CEO
|
|||
Martin Quinn
CMO and Co-Founder
|
|||
Paul Heneghan
Principal Engineer and Co-Founder
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Azin Parhizgar invest in?
Azin Parhizgar invests primarily in Health Care and Medical Device startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Azin Parhizgar?
Public channels for Azin Parhizgar include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Azin Parhizgar last invest?
The most recent investment recorded for Azin Parhizgar closed in Apr 2021. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
